Immatics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.About IMTX
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics.
CEOHarpreet Singh-Jasuja
CEOHarpreet Singh-Jasuja
Employees343
Employees343
HeadquartersTuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees343
Employees343
IMTX Key Statistics
Market cap1.03B
Market cap1.03B
Price-Earnings ratio-7.52
Price-Earnings ratio-7.52
Dividend yield—
Dividend yield—
Average volume350.35K
Average volume350.35K
High today$10.05
High today$10.05
Low today$9.77
Low today$9.77
Open price$9.84
Open price$9.84
Volume162.37K
Volume162.37K
52 Week high$13.16
52 Week high$13.16
52 Week low$6.46
52 Week low$6.46
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%